Previously unidentified protein variant shields against Parkinson’s disease

Wel­come to End­points News’ man­u­fac­tur­ing news briefs, where we bring you es­sen­tial up­dates on new builds, col­lab­o­ra­tions, re­calls and more. As­traZeneca CEO Pas­cal So­ri­ot said

Can­cer drug­mak­ers’ mar­ket­ing pay­ments to physi­cians do work, but they don’t im­prove pa­tient mor­tal­i­ty, ac­cord­ing to a new Na­tion­al Bu­reau of Eco­nom­ic Re­search work­ing pa­per.